RA patients | Controls | |||||
---|---|---|---|---|---|---|
SNP | Genotype counts | MAF | Genotype counts | MAF | P | OR (95% CI) |
PTPN22 rs2476601 | 1,383/325/35 | 0.11 | 1,405/235/10 | 0.08 | 4.61 × 10−7 | 1.53 (1.29 to 1.8) |
rs7726839 | 1,012/631/100 | 0.24 | 959/592/88 | 0.23 | ns | 1.02 (0.91 to 1.14) |
rs12573019 | 1,302/405/37 | 0.14 | 1,264/359/27 | 0.13 | ns | 1.11 (0.97 to 1.28) |
rs1168587 | 652/830/260 | 0.39 | 612/762/276 | 0.40 | ns | 0.97 (0.87 to 1.05) |
rs1895535 | 1,602/138/4 | 0.04 | 1,503/137/7 | 0.05 | ns | 0.91 (0.72 to 1.15) |
rs7200573 | 940/687/116 | 0.26 | 890/633/127 | 0.27 | ns | 0.97 (0.87 to 1.08) |
rs11865624 | 1,532/201/10 | 0.06 | 1,424/221/3 | 0.07 | ns | 0.92 (0.76 to 1.11) |
Anti-CCP + patients | Anti-CCP − patients | |||||
Positive/negative | Positive/negative | |||||
SE | 279/174b | 116/153b | 1.69 × 10−6 | 2.11 (1.56 to 2.88) | ||
GSTM1 | 402/376c | – | 186/192c | – | ns | 1.10 (0.86 to 1.41) |